Case Study: Boston Scientific achieves 23% annual marketing tech savings with Convertiv

Boston Scientific reduces marketing license costs by 23% with Convertiv

Boston Scientific, a major medical device company, faced challenges with a bloated and under-utilized marketing technology stack resulting from years of acquisitions and strategy shifts. This led to unreliable data, redundant technologies, and a significant portion of the marketing budget being consumed by underperforming subscriptions. Convertiv was engaged to perform a technology assessment and digital transformation to address these issues.

Convertiv conducted a deep dive into the MarTech stack, identifying business objectives and inventorying technologies. Their solution included a strategic roadmap to sunset redundant tools, establish a new Digital Center of Excellence for governance, and implement a modern data infrastructure. The results achieved by Convertiv included a 23% reduction in annual license costs, an 86% reduction in time-to-insight, and the creation of new processes for future technology evaluation and investment.

Boston Scientific